Comments
Loading...
TransCode Therapeutics Stock Short Interest Report | NASDAQ:RNAZ | Benzinga
Short interest in TransCode Therapeutics Inc (NASDAQ:RNAZ) increased during the last reporting period, rising from 162.85K to 540.93K. This put 77.7% of the company's publicly available shares short.
Short interest in TransCode Therapeutics Corp (XNAS:RNAZ) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 497.17K shares traded per day, it would take 1.09 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
540.93K
Short Interest %
77.7%
Days to Cover
1.09
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| RNAZ | TransCode Therapeutics, Inc. C | 02/28/2025 | 03/11/2025 | 77.70% | 696,201 | 540,931 | 497,170 | 1.09 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/14/2025 | 02/26/2025 | 23.39% | 696,201 | 162,852 | 3,210,769 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2025 | 02/11/2025 | 52.90% | 696,201 | 368,311 | 5,919,685 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/15/2025 | 01/27/2025 | 11.62% | 696,201 | 80,907 | 122,346 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/31/2024 | 01/10/2025 | 12.87% | 696,201 | 89,617 | 151,609 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/13/2024 | 12/24/2024 | 7.53% | 696,201 | 52,411 | 41,664 | 1.26 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/29/2024 | 12/10/2024 | 87.01% | 696,185 | 605,720 | 506,540 | 1.2 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2024 | 11/26/2024 | 1.25% | 17,264,090 | 215,516 | 441,966 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2024 | 11/11/2024 | 4.31% | 17,264,090 | 743,584 | 785,242 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/15/2024 | 10/24/2024 | 7.07% | 17,259,583 | 1,221,070 | 2,221,769 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/30/2024 | 10/09/2024 | 8.01% | 17,259,583 | 1,382,893 | 4,067,605 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/13/2024 | 09/24/2024 | 5.24% | 17,259,583 | 904,669 | 2,094,520 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/30/2024 | 09/11/2024 | 1.61% | 17,259,583 | 278,561 | 558,132 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2024 | 08/09/2024 | 9.48% | 17,259,583 | 1,635,985 | 3,100,733 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/15/2024 | 07/24/2024 | 0.14% | 17,259,583 | 24,679 | 243,038 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/28/2024 | 07/10/2024 | 2.30% | 7,259,583 | 167,182 | 204,296 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/14/2024 | 06/26/2024 | 6.18% | 7,259,583 | 448,481 | 548,613 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2024 | 06/11/2024 | 15.37% | 6,615,978 | 1,016,717 | 1,543,338 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2024 | 05/24/2024 | 2.63% | 6,615,978 | 173,933 | 4,193,007 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/30/2024 | 05/09/2024 | 2.45% | 6,101,978 | 149,637 | 487,873 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/15/2024 | 04/24/2024 | 0.30% | 6,101,978 | 18,555 | 431,855 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/28/2024 | 04/09/2024 | 0.69% | 5,802,275 | 39,956 | 159,852 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/15/2024 | 03/26/2024 | 16.63% | 1,050,594 | 174,746 | 372,975 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/29/2024 | 03/11/2024 | 9.71% | 1,050,594 | 101,999 | 386,632 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 02/15/2024 | 02/27/2024 | 21.03% | 1,050,594 | 220,911 | 928,318 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/31/2024 | 02/09/2024 | 71.89% | 1,050,594 | 755,303 | 1,682,463 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 01/12/2024 | 01/24/2024 | 37.51% | 1,050,594 | 394,050 | 3,285,323 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/29/2023 | 01/10/2024 | 1.63% | 24,866,480 | 404,996 | 1,159,267 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 12/15/2023 | 12/27/2023 | 1.76% | 24,866,480 | 437,534 | 2,135,505 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/30/2023 | 12/11/2023 | 2.56% | 24,884,323 | 637,234 | 4,389,636 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 11/15/2023 | 11/27/2023 | 2.43% | 19,884,323 | 483,318 | 1,832,496 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/31/2023 | 11/09/2023 | 6.64% | 19,884,323 | 1,321,234 | 16,002,850 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 10/13/2023 | 10/24/2023 | 1.70% | 11,734,774 | 199,359 | 1,980,017 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/29/2023 | 10/10/2023 | 0.62% | 11,734,774 | 72,766 | 15,974,194 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 09/15/2023 | 09/26/2023 | 4.70% | 2,687,401 | 126,378 | 756,285 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/31/2023 | 09/12/2023 | 1.34% | 1,812,401 | 24,365 | 22,152 | 1.1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 08/15/2023 | 08/24/2023 | 0.10% | 1,812,401 | 1,794 | 47,587 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/31/2023 | 08/09/2023 | 0.92% | 1,587,894 | 14,685 | 53,355 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 07/14/2023 | 07/25/2023 | 6.39% | 1,587,894 | 101,450 | 177,447 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/30/2023 | 07/12/2023 | 3.51% | 1,587,894 | 55,801 | 496,959 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 06/15/2023 | 06/27/2023 | 3.07% | 1,587,894 | 48,737 | 833,907 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/31/2023 | 06/09/2023 | 1.09% | 2,488,505 | 27,122 | 46,932 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 05/15/2023 | 05/24/2023 | 69.63% | 636,653 | 443,318 | 198,980 | 2.23 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/28/2023 | 05/09/2023 | — | 577,904 | 653,157 | 976,799 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 04/14/2023 | 04/25/2023 | — | 577,904 | 635,995 | 2,365,284 | 1 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/31/2023 | 04/12/2023 | 55.17% | 577,904 | 318,836 | 140,778 | 2.26 | Get Alert |
| RNAZ | TransCode Therapeutics, Inc. C | 03/15/2023 | 03/24/2023 | 45.34% | 581,004 | 263,451 | 330,374 | 1 | Get Alert |
Looking for the most shorted stocks?